Evercore ISI Group Initiates Coverage On Cardlytics With In-Line Rating, Announces Price Target of $4
Evercore ISI Group Initiates Coverage On Cardlytics With In-Line Rating, Announces Price Target of $4
Evercore ISI集團開始對cardlytics進行覆蓋，給予持平評級，並宣佈目標股價爲4美元
Evercore ISI Group analyst Mark Mahaney initiates coverage on Cardlytics (NASDAQ:CDLX) with a In-Line rating and announces Price Target of $4.
Evercore ISI Group分析師Mark Mahaney對Cardlytics（納斯達克:CDLX）發起覆蓋，給予一致評級，並宣佈目標股價爲$4。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間